SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
Article in BMC Medical Genomics (April 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in BMC Medical Genomics (April 2024)
Article in International Journal of Molecular Sciences (April 2024)
Article in BMC Cancer (January 2024)